| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 04/11/2019 | 12:08 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 08/08/2019 | 23:19 | Edgar (US Regulatory) | Notification That Quarterly Report Will Be Submitted Late (nt 10-q) | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 03/07/2019 | 12:00 | GlobeNewswire Inc. | FDA Accepts New Drug Application for INSYS Therapeutics’ Naloxone Nasal Spray for the Emergency Treatment of Known or Suspe... | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 24/06/2019 | 15:38 | Edgar (US Regulatory) | Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 12/06/2019 | 14:00 | GlobeNewswire Inc. | INSYS Therapeutics, Inc. Receives Court Approval of “First Day” Motions | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 10/06/2019 | 15:32 | Dow Jones News | Stocks to Watch: Salesforce.com, Insys, United Technologies, Barnes & Noble, Dunkin' Brands, and More | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 10/06/2019 | 12:07 | GlobeNewswire Inc. | INSYS Therapeutics Initiates Court-Supervised Process to Facilitate Asset Sales and Address Legacy Liabilities | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 07/06/2019 | 20:10 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 06/06/2019 | 23:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 06/06/2019 | 23:11 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 13/05/2019 | 12:02 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 11/05/2019 | 01:05 | GlobeNewswire Inc. | INSYS Therapeutics Reports First Quarter 2019 Results | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 30/04/2019 | 22:24 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 29/04/2019 | 18:38 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 15/04/2019 | 14:30 | GlobeNewswire Inc. | INSYS Therapeutics Implements Leadership Changes | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 08/04/2019 | 14:30 | GlobeNewswire Inc. | Report: Exploring Fundamental Drivers Behind Zscaler, Golden Star Resources, Flexion Therapeutics, SP Plus, Insys Therapeutic... | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 25/03/2019 | 11:00 | GlobeNewswire Inc. | INSYS Therapeutics to Present Poster of Pharmacokinetic Study of Naloxone Novel Nasal Spray at The College on Problems of Dru... | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 13/03/2019 | 11:08 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 07/03/2019 | 22:15 | GlobeNewswire Inc. | INSYS Therapeutics Reports Fourth Quarter and Full Year 2018 Results | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 06/03/2019 | 22:15 | GlobeNewswire Inc. | INSYS Therapeutics to Report Fourth Quarter and Full Year 2018 Results on March 7 | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 25/02/2019 | 12:00 | GlobeNewswire Inc. | INSYS Therapeutics Presented Poster of Initial Pharmacokinetic Study of Epinephrine Nasal Spray for the Emergency Treatment o... | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 19/02/2019 | 20:07 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 09/01/2019 | 12:00 | GlobeNewswire Inc. | INSYS Therapeutics Announces Results of Dose-Finding PK Study for Epinephrine Nasal Spray for Treatment of Anaphylaxis | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 03/01/2019 | 12:00 | GlobeNewswire Inc. | INSYS Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 18/12/2018 | 12:00 | GlobeNewswire Inc. | INSYS Therapeutics Announces Participation at FDA Advisory Committee Meeting Addressing the Co-Prescribing of Naloxone | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 17/12/2018 | 12:00 | GlobeNewswire Inc. | INSYS Therapeutics Provides Update on Strategic Alterative Review Process and Product Pipeline Spanning Pharmaceutical Cannab... | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 04/12/2018 | 12:00 | GlobeNewswire Inc. | INSYS Therapeutics Presents New Clinical Data from Long-Term Safety Study of CBD Oral Solution in Refractory Pediatric Epile... | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 20/11/2018 | 13:00 | GlobeNewswire Inc. | Clinical Data from Long-Term Safety-Study of Company’s Pharmaceutical CBD in Refractory Pediatric Epilepsy To Be Presented... | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 06/11/2018 | 14:45 | InvestorWire | As the Cannabis Industry Grows, So Do Challenges of Supply and Distribution | NASDAQ:INSY | Insys Therapeutics, Inc. |
| 05/11/2018 | 22:16 | GlobeNewswire Inc. | INSYS Therapeutics Reports Third Quarter 2018 Results | NASDAQ:INSY | Insys Therapeutics, Inc. |